Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Brain Tumor Pathol ; 31(3): 162-71, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24202294

ABSTRACT

The purpose of the study was to investigate the pathological and clinical significance of the expression of nestin, a type-VI intermediate filament transiently expressed during brain development, in glioma tissue. This study was conducted in 70 patients with newly diagnosed adult supratentorial gliomas who underwent multimodality treatment in our department, including surgery. The pathological diagnosis was grade II in 6 patients, grade III in 21 patients, and grade IV in 43 patients. Two specimen sections, one from the bulk of the removed tumor and one from the border between the tumor and normal brain tissue, were subjected to immunostaining with a mouse anti-human nestin monoclonal antibody. Analyses were performed to investigate possible correlation with pathological features, the relationship between nestin expression and the continuity of tumor with the subventricular zone (SVZ), correlation with the therapeutic prognosis, etc. Nestin was expressed specifically in astrocytoma lineage cells. In oligodendroglial tumors, nestin was expressed only in less-differentiated cells and cells suggestive of the presence of astrocytoma. In astrocytic tumors, the rate and level of nestin expression increased as the degree of malignancy increased. There was no significant correlation between the expression level of nestin and the continuity of tumor with the SVZ in the contrast-enhanced imaging before surgery. In addition, no correlation with the therapeutic prognosis was observed. Nestin, a neural stem cell marker, was specifically expressed in astrocytoma lineage cells in glioma tissue. A positive correlation was observed between the degree of malignancy and the level of nestin expression. However, the level of nestin expression was not related to the tumor localization in the SVZ and was not correlated with the therapeutic prognosis.


Subject(s)
Biomarkers, Tumor/analysis , Brain Neoplasms/diagnosis , Brain Neoplasms/pathology , Glioma/diagnosis , Glioma/pathology , Nestin/analysis , Neural Stem Cells/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Astrocytoma/diagnosis , Astrocytoma/pathology , Female , Humans , Immunohistochemistry , Lateral Ventricles , Male , Middle Aged , Neoplasm Staging , Young Adult
2.
Pathol Int ; 63(10): 492-5, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24147429

ABSTRACT

Extramedullary hematopoiesis (EMH) suggests the presence of hematopoietic stem cells (HSC) outside bone marrow. EMH has been reported, albeit rarely, in pyogenic granuloma (PG), a polypoid lobular capillary hemangioma. However, statistical data have hitherto been lacking on the actual incidence of EMH in PG. Therefore, we here reviewed 157 consecutive cases using routine diagnostic surgical slides and found unequivocal EMH in 17 (10.8%). This indicates that EMH is a rather common finding in PG, which could thus have strong potential to be an important resource for the study of HSC.


Subject(s)
Granuloma, Pyogenic/complications , Hematopoiesis, Extramedullary , Adolescent , Adult , Aged , Female , Humans , Incidence , Male , Middle Aged , Young Adult
3.
Cell Mol Neurobiol ; 31(5): 795-802, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21476018

ABSTRACT

Following endoplasmic reticulum (ER) stress, cerebral infarctions have been reported to involve an apoptotic process, including the activation of the caspase cascade. To confirm whether fragmented caspase-12, which is activated by cleavage and is detectable during ER stress, is also involved in embolic cerebral infarctions in rats, we adopted an autologous blood clot model for the analysis of cerebral infarctions. We performed experiments in rats with brain infarctions, which are closely related to embolic cerebral infarctions. We utilized a homologous blood clot, i.e., natural materials, to form the infarct area. Our findings reveal that caspase-12 is fragmented when infarct areas form in cerebral cortical neurons. Interestingly, we observed that these fragments translocated to the nuclei of not only cerebral cortical neurons but hippocampal neurons. We further found that glucose-regulated protein 78 (GRP78), a marker of ER stress, is up-regulated in both cerebral cortical and hippocampal neurons during cerebral infarction. This result suggests that the fragmentation of caspase-12 and the subsequent nuclear translocation of these fragments are involved in the brain infarction process in rats.


Subject(s)
Brain Infarction/pathology , Caspase 12/metabolism , Cell Nucleus/enzymology , Cerebral Cortex/pathology , Hippocampus/pathology , Intracranial Embolism/pathology , Neurons/enzymology , Animals , Apoptosis , Brain Infarction/complications , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum/pathology , Heat-Shock Proteins/metabolism , In Situ Nick-End Labeling , Intracranial Embolism/complications , Male , Models, Biological , Neurons/pathology , Peptide Fragments/metabolism , Protein Transport , Rats , Rats, Wistar , Staining and Labeling , Stress, Physiological , Thrombosis/complications , Thrombosis/pathology
4.
Neurosci Lett ; 470(2): 139-44, 2010 Feb 12.
Article in English | MEDLINE | ID: mdl-20056130

ABSTRACT

Cyclophosphamide (CP) has been used as an antitumour agent or immunosuppressant clinically, though the potential biological role of CP in the central nervous system (CNS) has not been clarified. In the present study, we found that pretreatment with CP prevented neuronal cell death caused by serum deprivation in cultured cortical neurons. Interestingly, CP stimulated activation of PI3K (phosphatidylinositol 3 kinase) and MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) pathways, which are known as survival-promoting intracellular signalings. Furthermore, CP increased the expression of Bcl2, an anti-apoptotic factor. In the presence of inhibitors for PI3K or MAPK/ERK pathways, the CP-dependent neuronal survival and Bcl-2 up-regulation were both abolished. Importantly, significant increase in BDNF (brain-derived neurotrophic factor) expression was induced by CP application, implying that BDNF up-regulation is involved in the CP effect. We propose that CP has a protective effect on CNS neurons via the activation of intracellular signalings, and up-regulation of Bcl2 and BDNF.


Subject(s)
Cerebral Cortex/drug effects , Cyclophosphamide/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Animals , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/physiology , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Neurons/physiology , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Signal Transduction/drug effects , Signal Transduction/physiology
5.
Neurosci Lett ; 469(3): 303-8, 2010 Jan 29.
Article in English | MEDLINE | ID: mdl-20025928

ABSTRACT

Many studies suggest that antidepressants act as neuroprotective agents in the central nervous system (CNS), though the underlying mechanism has not been fully elucidated. In the present study, we examined the effect of SA4503, which is a sigma-1 receptor agonist and a novel antidepressant candidate, on oxidative stress-induced cell death in cultured cortical neurons. Exposure of the neurons to H(2)O(2) induced cell death, while pretreatment with SA4503 inhibited neuronal cell death. The SA4503-dependent survival effect was reversed by co-application with BD1047 (an antagonist of sigma-1/2 receptors). Previously we found that H(2)O(2) triggers a series of events including over-activation of mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) and intracellular Ca(2+) accumulation via voltage-gated Ca(2+) channels and ionotropic glutamate receptors, resulting in neuronal cell death (Numakawa et al. (2007) [20]). Importantly, we found in this study that SA4503 reduced the activation of the MAPK/ERK pathway and down-regulated the ionotropic glutamate receptor, GluR1. Taking these findings together, it is possible that SA4503 blocks neuronal cell death via repressing activation of the MAPK/ERK pathway and, consequently, expression levels of glutamate receptors.


Subject(s)
Cerebral Cortex/drug effects , Neurons/drug effects , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Piperazines/pharmacology , Receptors, sigma/agonists , Animals , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured , Central Nervous System Agents/pharmacology , Cerebral Cortex/physiology , Enzyme Activation/drug effects , Ethylenediamines/pharmacology , Extracellular Signal-Regulated MAP Kinases/metabolism , Hydrogen Peroxide/toxicity , MAP Kinase Signaling System/drug effects , Neurons/physiology , Oxidants/toxicity , Oxidative Stress/physiology , Rats , Receptors, AMPA/metabolism , Receptors, Glutamate/metabolism , Receptors, sigma/antagonists & inhibitors , Receptors, sigma/metabolism
6.
Brain Tumor Pathol ; 26(2): 59-68, 2009.
Article in English | MEDLINE | ID: mdl-19856216

ABSTRACT

Our aim was to extract the radiopathological features of cerebellar malignant glioma in adults from the four cases we encountered. All four cases (two men and two women, aged 52-80 years; mean age, 67 years) had a floating sensation or vertigo at the onset of their disease. Initially, these patients were given a diagnosis of cerebellar infarction or cavernous angioma, or had faint abnormalities in the cerebellum that were overlooked. These patients were followed up for 2-14 months (mean, 6 months), and the tumor was detected when their clinical symptoms deteriorated. The tumor was located in the hemisphere in one patient and in the vermis in three patients. MRI revealed ring-like enhancement in two patients and nodular enhancement in two patients. All patients underwent subtotal tumor resection, followed by postoperative radiochemotherapy. However, three patients died at 16 to 44 months (mean, 28 months), and cerebrospinal fluid (CSF) dissemination was observed in three patients. Two cases were classified as WHO grade III and two as WHO grade IV. The pathological features were typical of malignant glioma, partially presenting the features of low-grade glioma, such as pilocytic, astrocytic, or oligodendroglial components. Nuclear pleomorphism and vascular endothelial proliferation were prominent, and micronecrosis was relatively less evident. The MIB-1 index was 12%-40%, and most of the patients were p53 protein positive. At the onset of cerebellar malignant glioma, diagnostic imaging shows few signs of brain tumor. Thereafter, tumors grow in a short period of time, following a rapid clinical course. Because cerebellar malignant glioma is a rare disease, it is difficult to differentiate it from metastatic brain tumors and primary central nervous system lymphoma by preoperative imaging. Some patho logical features suggesting malignant transformation from low-grade glioma were detected.


Subject(s)
Cerebellar Neoplasms/diagnostic imaging , Cerebellum/diagnostic imaging , Glioma/diagnostic imaging , Aged , Aged, 80 and over , Cerebellar Neoplasms/pathology , Cerebellum/metabolism , Cerebellum/pathology , Fatal Outcome , Female , Glioma/pathology , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Ki-67 Antigen/metabolism , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Radiography , Staining and Labeling , Tumor Suppressor Protein p53/metabolism
7.
Biochem Biophys Res Commun ; 388(2): 366-71, 2009 Oct 16.
Article in English | MEDLINE | ID: mdl-19665996

ABSTRACT

Paclitaxel (also known as Taxol) is a well-known anticancer agent that blocks cell mitosis and kills tumor cells, and is often used in clinic to treat cancers. Despite the success of Paclitaxel, the development of drug resistance prevents its clinical applicability. Here, we screened an siRNA library against the entire human genomes using HeLa cells, and have find that lack of USP15 (ubiquitin-specific protease 15) causes Paclitaxel resistance. We also observed the decreased expression of USP15 in Paclitaxel-resistant human ovarian cancer samples. In addition, we have demonstrated that USP15 plays an essential role for stability and activity of caspase-3 during Paclitaxel-induced apoptosis. Thus, USP15 may be a candidate diagnostic marker and therapeutic target for Paclitaxel-resistant cancers.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis , Caspase 3/biosynthesis , Endopeptidases/metabolism , Paclitaxel/pharmacology , Tubulin Modulators/pharmacology , Drug Resistance, Neoplasm/genetics , Endopeptidases/genetics , Enzyme Activation , Gene Knockdown Techniques , HeLa Cells , Humans , RNA, Small Interfering/genetics , Ubiquitin-Specific Proteases
8.
Radiat Res ; 172(1): 66-73, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19580508

ABSTRACT

The aim of this study was to determine whether albumin leakage and dark neurons were present in rat brains 14 and 50 days after a single 2-h exposure to a 915 MHz electromagnetic field, as reported by Salford et al. (Environ. Health Perspect. 111, 881-883, 203). Sixty-four male F344 rats (12 weeks old) were exposed to a 915 MHz electromagnetic field at whole-body average specific absorption rates of 0, 0.02, 0.2 and 2.0 W/kg in TEM cells for 2 h, following the protocol reported by Salford et al. The brains were examined histologically and immunohistochemically. No albumin immunoreactivity was observed in the exposed groups. In addition, dark neurons, assessed using hematoxylin and eosin staining, were rarely present, with no statistically significant difference between exposed and sham-exposed animals. This study thus failed to confirm the results of Salford et al.


Subject(s)
Blood-Brain Barrier/radiation effects , Brain/radiation effects , Electromagnetic Fields , Neurons/radiation effects , Analysis of Variance , Animals , Blood-Brain Barrier/pathology , Body Weight/radiation effects , Brain/metabolism , Brain/pathology , Capillary Permeability/radiation effects , Immunohistochemistry , Male , Radiation Dosage , Rats , Rats, Inbred F344 , Serum Albumin/metabolism
9.
PLoS One ; 4(5): e5532, 2009.
Article in English | MEDLINE | ID: mdl-19440243

ABSTRACT

BACKGROUND: MicroRNAs are a family of 19- to 25-nucleotides noncoding small RNAs that primarily function as gene regulators. Aberrant microRNA expression has been described for several human malignancies, and this new class of small regulatory RNAs has both oncogenic and tumor suppressor functions. Despite this knowledge, there is little information regarding microRNAs in plasma especially because microRNAs in plasma, if exist, were thought to be digested by RNase. Recent studies, however, have revealed that microRNAs exist and escape digestion in plasma. METHODOLOGY/PRINCIPAL FINDINGS: We performed microRNA microaray to obtain insight into microRNA deregulation in the plasma of a leukemia patient. We have revealed that microRNA-638 (miR-638) is stably present in human plasmas, and microRNA-92a (miR-92a) dramatically decreased in the plasmas of acute leukemia patients. Especially, the ratio of miR-92a/miR-638 in plasma was very useful for distinguishing leukemia patients from healthy body. CONCLUSIONS/SIGNIFICANCE: The ratio of miR-92a/miR-638 in plasma has strong potential for clinical application as a novel biomarker for detection of leukemia.


Subject(s)
Leukemia/blood , Leukemia/genetics , MicroRNAs/blood , Female , Gene Expression Regulation, Neoplastic/genetics , Gene Expression Regulation, Neoplastic/physiology , Humans , In Situ Hybridization , Leukemia, Myeloid, Acute/blood , Leukemia, Myeloid, Acute/genetics , Male , MicroRNAs/genetics , Oligonucleotide Array Sequence Analysis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Reverse Transcriptase Polymerase Chain Reaction
10.
Am J Pathol ; 174(1): 309-16, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19056850

ABSTRACT

Heterochromatin protein 1 (HP1) is a chromosomal protein that participates in both chromatin packaging and gene silencing. Three HP1 isoforms (alpha, beta, and gamma) occur in mammals, but their functional differences are still incompletely understood. In this study, we found that HP1gamma levels are decreased during adipocyte differentiation, whereas HP1alpha and beta levels are expressed constitutively during adipogenesis in cultured preadipocyte cells. In addition, ectopic overexpression of HP1gamma inhibited adipogenesis. Furthermore, we did not detect any HP1gamma protein in the differentiated cells of various normal human tissues. These results suggest that the loss of HP1gamma is required for cell differentiation to occur. On the other hand, the methylation levels of lysine 20 (K20) on histone H4 showed a significant correlation with HP1gamma expression in both these preadipocyte cells and normal tissue samples. However, all cancer tissues examined were positive for HP1gamma but were often negative for trimethylated histone H4 K20. Thus, a dissociation of the correlation between HP1gamma expression and histone H4 K20 trimethylation may reflect the malfunction of epigenetic control. Finally, suppression of HP1gamma expression restrained cell growth in various cancer-derived cell lines, suggesting that HP1gamma may be an effective target for gene therapy against various human cancers. Taken together, our results demonstrate the novel function of HP1gamma in the epigenetic regulation of both cell differentiation and cancer development.


Subject(s)
Cell Differentiation/genetics , Chromosomal Proteins, Non-Histone/genetics , Chromosomal Proteins, Non-Histone/metabolism , Epigenesis, Genetic , Neoplasms/genetics , Adipocytes/cytology , Blotting, Western , Cell Line, Tumor , Chromobox Protein Homolog 5 , Histones/metabolism , Humans , Immunohistochemistry , Neoplasms/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA Interference
11.
Mol Endocrinol ; 22(3): 546-58, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18096693

ABSTRACT

An increased level of glucocorticoid may be related to the pathophysiology of depressive disorder. The involvement of brain-derived neurotrophic factor (BDNF) in the antidepressive effect has also been suggested; however, the possible influence of glucocorticoid on the action of BDNF in the developing central nervous system has not been elucidated. In this study, we investigated the effect of glucocorticoid (dexamethasone, DEX) on synaptic maturation and function enhanced by BDNF in early developing hippocampal neurons. In the immature stage, BDNF increased the outgrowth of dendrites and the expression of synaptic proteins including glutamate receptors and presynaptic proteins. Pretreatment with DEX significantly inhibited the BDNF-dependent up-regulation of both dendritic outgrowth and synaptic proteins. In the more mature stage, the BDNF-reinforced postsynaptic Ca(2+) influx was decreased by DEX. BDNF-enhanced presynaptic glutamate release was also suppressed. RU486, a glucocorticoid receptor antagonist, canceled the DEX-dependent blocking effect on the action of BDNF. After down-regulation of glucocorticoid receptor by small interfering RNA application, no inhibitory effect of DEX on the BDNF-increased synaptic proteins was observed. Interestingly, the BDNF-activated MAPK/ERK pathway, which is an essential intracellular signaling pathway for the BDNF-increased synaptic proteins, was reduced by DEX. These results suggest that BDNF-mediated synaptic maturation is disturbed after neurons are exposed to high-level glucocorticoid in their development stage.


Subject(s)
Brain-Derived Neurotrophic Factor/antagonists & inhibitors , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Hippocampus/drug effects , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Synapses/drug effects , Animals , Brain-Derived Neurotrophic Factor/physiology , Butadienes/pharmacology , Calcium/metabolism , Glutamic Acid/metabolism , Hippocampus/metabolism , Hippocampus/physiology , Hormone Antagonists/pharmacology , Immunoblotting , Mifepristone/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Neurons/drug effects , Neurons/metabolism , Neurons/physiology , Nitriles/pharmacology , Protein Kinase Inhibitors/pharmacology , RNA, Small Interfering/pharmacology , Rats , Synapses/physiology
12.
Blood ; 111(4): 1903-12, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18042804

ABSTRACT

Interleukin (IL)-27, one of the most recently discovered IL-6 family cytokines, activates both the signal transducer and activator of transcription (STAT)1 and STAT3, and plays multiple roles in pro- and anti-inflammatory immune responses. IL-27 acts on various types of cells including T, B, and macrophage through the common signal-transducing receptor gp130 and its specific receptor WSX-1, but the effect of IL-27 on hematopoietic stem cells (HSCs) remains unknown. Here, we show that IL-27 together with stem cell factor (SCF) directly acts on HSCs and supports their early differentiation in vitro and in vivo. CD34(-/low)c-Kit(+)Sca-1(+)lineage marker(-) (CD34(-)KSL) cells, a population highly enriched in mouse HSCs, were found to express both IL-27 receptor subunits. In vitro cultures of CD34(-)KSL cells with IL-27 and SCF resulted in an expansion of progenitors including short-term repopulating cells, while some of their long-term repopulating activity also was maintained. To examine its in vivo effect, transgenic mice expressing IL-27 were generated. These mice exhibited enhanced myelopoiesis and impaired B lymphopoiesis in the bone marrow with extramedullary hematopoiesis in the spleen. Moreover, IL-27 similarly acted on human CD34(+) cells. These results suggest that IL-27 is one of the limited cytokines that play a role in HSC regulation.


Subject(s)
Cell Differentiation/drug effects , Hematopoietic Stem Cells/cytology , Interleukins/pharmacology , Animals , Antigens, CD34/analysis , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , DNA Primers , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/genetics , Hematopoietic Stem Cells/drug effects , Humans , Mice , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction
13.
J Neurosci Res ; 85(13): 2933-42, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17628025

ABSTRACT

The mechanism by which MCI-186 (3-methyl-1-phenyl-2-prazolin-5-one) exerts protective effects during cerebral infarction, other than its function as a radical scavenger, has not been fully elucidated. Here, we found that MCI-186 stimulates intracellular survival signaling in vivo and in vitro. In a rat infarction model, the infarct area was significantly smaller and the degree of edema was reduced in MCI-186-treated animals. In the MCI-186-treated rats, the number of single stranded (ss) DNA-positive damaged cells in the peri-infarct area was decreased compared with the control, suggesting that MCI-186 protects cerebral tissues from cell damage. To clarify the mechanisms underlying the effect of MCI-186, we also examined the survival-promoting effect of this agent on cultured cortical neurons. In this in vitro system, MCI-186 blocked serum-free induced neuronal cell death. Interestingly, an increase in the activation of both Akt (a component of the PI3 kinase pathway) and ERK (a component of the MAP kinase pathway) was observed in the cortical cultures after MCI-186 exposure. Furthermore, the MCI-186-dependent survival effect in vitro was blocked by U0126, an MEK (an upstream of ERK) inhibitor, and also by LY294002, a PI3 kinase inhibitor. We also observed similar increases in the activation of Akt and ERK in the in vivo model, further suggesting that the antiapoptotic role of MCI-186 is mediated via the PI3 kinase and MAP kinase signaling pathways. We therefore conclude that, in addition to its role as a free radical scavenger, MCI-186 functions as an antiapoptotic factor by enhancing intracellular survival signaling.


Subject(s)
Antipyrine/analogs & derivatives , Cerebral Infarction/drug therapy , Cerebral Infarction/pathology , Free Radical Scavengers/therapeutic use , Neurons/drug effects , Signal Transduction/drug effects , Animals , Animals, Newborn , Antipyrine/therapeutic use , Brain Edema/etiology , Brain Edema/prevention & control , Butadienes/pharmacology , Cell Death/drug effects , Cells, Cultured , Chromones/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Edaravone , Enzyme Inhibitors/pharmacology , Male , Morpholines/pharmacology , Nerve Tissue Proteins/metabolism , Nitriles/pharmacology , Oncogene Protein v-akt/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Rats , Rats, Wistar , Time Factors
14.
Med Mol Morphol ; 40(2): 95-102, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17572845

ABSTRACT

Gestational trophoblastic disease (GTD) is a unique spectrum of diseases ranging from complete hydatidiform mole (CHM), partial hydatidiform mole (PHM), and invasive mole (IM) to choriocarcinoma (CC). Placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT) have been classified as related disorders. Mesenchymal dysplasia (MD) may be misdiagnosed as PHM; however, it is said to have a quite different histogenesis from PHM. P57kip2 is the protein product of a paternally imprinted or maternal gene that inhibits cyclin-dependent kinases (CDK), thus serving to inhibit cell proliferation and to suppress tumor growth. Its lack of expression in trophoblastic disease plays a role in its abnormal proliferation and differentiation. In this study, P57kip2 immunostaining was absent in the trophoblastic layers of CHM and was positive in the trophoblast layer of nonmolar villi and MD. Ultrastructure of complete molar cystic villi showed tree-like branching of microvillous processes and intracytoplasmic lacunae without capillaries in the stroma, whereas MD contained many newly formed blood vessels and collagen. Also, large lacunae with microvilli and polymorphic nuclei of syncytiotrophoblast cells with well-developed organelles were observed in IM. Lung ETT following CHM and normal deliveries showed two types of large mononuclear cells and binuclear cells with abundant organelles and bundles of intermediate-type filaments in the stroma.


Subject(s)
Biomarkers, Tumor/analysis , Chorionic Villi/ultrastructure , Cyclin-Dependent Kinase Inhibitor p57/analysis , Gestational Trophoblastic Disease/classification , Gestational Trophoblastic Disease/pathology , Mesoderm/ultrastructure , Abortion, Spontaneous/pathology , Adult , Carcinoma/pathology , Carcinoma/ultrastructure , Chorionic Villi/chemistry , Cyclin-Dependent Kinases/analysis , Diagnosis, Differential , Female , Gene Expression Regulation, Neoplastic , Humans , Hydatidiform Mole/pathology , Immunohistochemistry , Mesoderm/pathology , Placental Lactogen/analysis , Placental Lactogen/chemistry , Pregnancy , Uterine Cervical Dysplasia/embryology , Uterine Cervical Dysplasia/pathology
15.
Neurol Med Chir (Tokyo) ; 46(7): 353-7, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16861830

ABSTRACT

A 48-year-old woman with a history of viral influenza infection was admitted with rapidly progressive numbness and weakness of the right extremities. On admission, general physical examination revealed no abnormality. Cerebrospinal fluid analysis showed no abnormal findings. Brain computed tomography and magnetic resonance imaging showed an open ring-like enhanced lesion in the white matter of the right parietal lobe with massive perifocal edema. Cerebral angiography showed no tumor staining and thallium-201 single photon emission computed tomography showed no abnormal uptake. The preoperative diagnosis was malignant glioma and partial resection was performed. Histological examination showed perivascular accumulation of small lymphocytes and a large number of macrophages with reactive astrocytes. Phagocytosis of myelin was observed in the macrophages and nuclear fragmentation in the reactive astrocytes. The histological diagnosis was acute inflammatory demyelinating disease. After therapy with methylprednisolone, her neurological symptoms improved gradually and no relapse occurred during 18 months of follow up. Tumor-like masses of demyelination may occupy an intermediate position between acute multiple sclerosis and postinfectious encephalitis. Open ring sign may be a pathognomonic feature of these lesions.


Subject(s)
Brain/pathology , Demyelinating Diseases/complications , Demyelinating Diseases/pathology , Inflammation/complications , Inflammation/pathology , Brain/surgery , Demyelinating Diseases/surgery , Female , Humans , Lymphocytes/pathology , Macrophages/pathology , Magnetic Resonance Imaging , Middle Aged , Preoperative Care
16.
J Immunol ; 176(12): 7317-24, 2006 Jun 15.
Article in English | MEDLINE | ID: mdl-16751375

ABSTRACT

IL-27 is a novel IL-6/IL-12 family cytokine playing an important role in the early regulation of Th1 responses. We have recently demonstrated that IL-27 has potent antitumor activity, which is mainly mediated through CD8(+) T cells, against highly immunogenic murine colon carcinoma. In this study, we further evaluated the antitumor and antiangiogenic activities of IL-27, using poorly immunogenic murine melanoma B16F10 tumors, which were engineered to overexpress single-chain IL-27 (B16F10 + IL-27). B16F10 + IL-27 cells exerted antitumor activity against not only s.c. tumor but also experimental pulmonary metastasis. Similar antitumor and antimetastatic activities of IL-27 were also observed in IFN-gamma knockout mice. In NOD-SCID mice, these activities were decreased, but were still fairly well-retained, suggesting that different mechanisms other than the immune response are also involved in the exertion of these activities. Immunohistochemical analyses with Abs against vascular endothelial growth factor and CD31 revealed that B16F10 + IL-27 cells markedly suppressed tumor-induced neovascularization in lung metastases. Moreover, B16F10 + IL-27 cells clearly inhibited angiogenesis by dorsal air sac method, and IL-27 exhibited dose-dependent inhibition of angiogenesis on chick embryo chorioallantoic membrane. IL-27 was revealed to directly act on HUVECs and induce production of the antiangiogenic chemokines, IFN-gamma-inducible protein (IP-10) and monokine induced by IFN-gamma. Finally, augmented mRNA expression of IP-10 and monokine induced by IFN-gamma was detected at the s.c. B16F10 + IL-27 tumor site, and antitumor activity of IL-27 was partially inhibited by the administration of anti-IP-10. These results suggest that IL-27 possesses potent antiangiogenic activity, which plays an important role in its antitumor and antimetastatic activities.


Subject(s)
Angiogenesis Inhibitors/physiology , Antineoplastic Agents/pharmacology , Interleukins/physiology , Angiogenesis Inhibitors/administration & dosage , Animals , Antineoplastic Agents/administration & dosage , Cell Line , Chick Embryo , Growth Inhibitors/physiology , Humans , Injections, Subcutaneous , Interferon-gamma/deficiency , Interferon-gamma/genetics , Interleukins/pharmacology , Lung Neoplasms/blood supply , Lung Neoplasms/prevention & control , Lung Neoplasms/secondary , Melanoma, Experimental , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Neoplasm Transplantation , Neovascularization, Pathologic/prevention & control , Recombinant Proteins/pharmacology
18.
Med Mol Morphol ; 38(2): 92-103, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15944816

ABSTRACT

The placenta is an important functional unit for gas transfer between mother and fetus. The placental membrane, consisting of trophoblast layer interposed between maternal and fetal blood, plays an active role for intensity of respiration, but no morphological evidence has been documented. Until now, it has been reported that fetal growth retardation and increased fetal mortality rate usually could be seen at high altitude. In an attempt to find the cause of high perinatal mortality rate in Nepal, this study was undertaken to examine pathologically about 1000 Himalayan placentas obtained in Nepal and Tibet since 1977, and the results were compared with those of 5500 Japanese placentas at Saitama Medical School since 1990. In this study, characteristics of ultrastructural features of the Nepalese placental villi investigated in recent years are reported. (1) The gross characteristics of placental pathology in the Himalayan group were represented by marked subchorionic fibrin deposits and increased chorionic cysts in contrast to low incidence of intervillous thrombosis compared with those of the Japanese group. (2) As characteristics of histological findings of the placental villi between Himalayan and Japanese groups, the incidence of chorangiosis and chorangioma in the Himalayan group was significantly higher than that in the Japanese group. (3) Accompanying an increase of vasculosyncytial membrane (VSM) in the villi, thickness and separation of basement membrane of the syncytium in addition to increased apoptosis of syncytial cell nuclei were recognized. (4) As characteristic ultrastructural features of chorionic villi of Nepalese placentas, an increase of mitochondria and cystic formation of rough endoplasmic reticulum (rER), in addition to appearance of lamellar bodies similar to alveolar epithelial type II cell in organellae of the syncytium, were observed. These ultrastructural changes of the placental villous capillaries may be ascribed to hypervascularization caused by the chronic hypoxic state. It is, therefore, presumed that trophoblast cells may play an important role for gas transfer mechanism under such a hypoxic state at high altitude.


Subject(s)
Altitude , Chorionic Villi/pathology , Chorionic Villi/ultrastructure , Adult , Female , Humans , Nepal , Pregnancy
19.
Brain Tumor Pathol ; 22(1): 21-7, 2005.
Article in English | MEDLINE | ID: mdl-18095100

ABSTRACT

A 43-year-old woman who had undergone breast cancer surgery 1 year previously complained of headache and nausea. Her brain computed tomography (CT) scan and magnetic resonance imaging (MRI) showed a well-circumscribed, heterogeneously enhanced tumor in the right thalamus. She underwent gross total resection of the tumor followed by radiochemotherapy, and her clinical course was uneventful after surgery. Histological examination revealed a moderate number of tumor cells with fine bipolar processes in a mucoid matrix, which suggested pilocytic astrocytoma. The tumor was associated with microvascular proliferation but did not show significant mitosis or necrosis. In some areas, it had an epithelioid appearance, with ribbon-like, cribriform, and pseudoglandular patterns involving cuboid-shaped cells showing nuclear atypia and mitotic figures. Immunohistochemically, the tumor cells were positive for glial fibrillary acidic protein (GFAP) and vimentin in the area resembling pilocytic astrocytoma, but in the epithelioid area they were negative for GFAP and vimentin as well as for breast cancer markers, including AE1/AE3. The proliferating potential, represented by the MIB-1 labeling index, was high (82.5%) in the area of epithelioid appearance, compared to only 3% in the area of pilocytic astrocytoma-like appearance. As a rare histoarchitectural variant of glioblastoma, the epithelioid pattern may represent a very primitive tumor cell phenotype. Typically, this pattern is characterized by well-circumscribed masses, although its clinical significance is unknown.


Subject(s)
Brain Neoplasms/pathology , Glioblastoma/pathology , Neoplasms, Second Primary/pathology , Adult , Antineoplastic Agents, Hormonal/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/therapy , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/drug therapy , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/surgery , Chemotherapy, Adjuvant , Combined Modality Therapy , Female , Glioblastoma/therapy , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Neurosurgical Procedures , Radiotherapy, Adjuvant , Tomography, X-Ray Computed
20.
Brain Res ; 1028(1): 105-11, 2004 Nov 26.
Article in English | MEDLINE | ID: mdl-15518647

ABSTRACT

Brain-derived neurotrophic factor (BDNF), one of the neurotrophic factors acting in the central nervous system (CNS), prevents ordinary types of neuronal cell death induced by various stimulants. On the other hand, an accumulation of unfolded proteins in the endoplasmic reticulum (ER) leads to ER stress and then induces ER stress-mediated cell death. The ER stress-mediated cell death is distinctive because the caspase-12 activity plays a crucial role in the progression of cell death. We previously showed that nerve growth factor (NGF) attenuated ER stress-mediated cell death in non-neuronal PC12 cells. Here, we report that BDNF suppressed the ER stress-mediated cell death in tunicamycin (Tm)-treated cerebral cortical neurons. An analysis using a specific inhibitor of phosphatidylinositol 3-kinase (PI3-K), LY294002, revealed that BDNF prevented this cell death via the PI3-K signaling pathway. We found that the number of NeuN/TUNEL-double positive cells and the activity of caspase-3 suppressed by BDNF were increased by LY294002. We also discovered that LY294002 diminished the effect of BDNF on the activation of caspase-12, indicating that BDNF prevents ER stress-mediated cell death via a PI3-K-dependent mechanism by suppressing the activation of caspase-12 in cultured CNS neurons.


Subject(s)
Brain-Derived Neurotrophic Factor/physiology , Caspases/metabolism , Cell Death/physiology , Cerebral Cortex/physiology , Endoplasmic Reticulum/enzymology , Phosphatidylinositol 3-Kinases/metabolism , Analysis of Variance , Animals , Caspase 12 , Caspase 3 , Caspases/drug effects , Cell Death/drug effects , Cell Line , Cerebral Cortex/cytology , Chromones/pharmacology , Endoplasmic Reticulum/drug effects , Enzyme Inhibitors/pharmacology , Morpholines/pharmacology , Neurons/cytology , Neurons/drug effects , Neurons/physiology , Phosphatidylinositol 3-Kinases/drug effects , Rats , Signal Transduction/drug effects , Signal Transduction/physiology , Tunicamycin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...